---
title: "APEX-AV trial results of AlphaVac PE system published in JSCAI"
date: "2025-01-13T16:43:20.000Z"
publishedDate: "13 janvier 2025"
summary: "AngioDynamics has announced the publication of the results from the Acute Pulmonary Embolism Extraction Trial with the AlphaVac system—APEX-AV—in the Journal of the Society for Cardiovascular Angiography &#38; Interventions (JSCAI). The primary efficacy endpoint of the APEX-AV trial was the reduction in right ventricle to left ventricle (RV/LV) ratio between baseline and 48 hours post-procedure."
importance: ""
sourceUrl: "https://cardiovascularnews.com/apex-av-trial-results-of-alphavac-pe-system-published-in-jscai/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-01-13-apex-av-trial-results-of-alphavac-pe-system-published-in-jscai"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/01/AngioDynamics-AlphaVac-featured.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/apex-av-trial-results-of-alphavac-pe-system-published-in-jscai/"
---

![APEX-AV trial results of AlphaVac PE system published in JSCAI](https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/01/AngioDynamics-AlphaVac-featured.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/apex-av-trial-results-of-alphavac-pe-system-published-in-jscai/*

## L’essentiel

AngioDynamics has announced the publication of the results from the Acute Pulmonary Embolism Extraction Trial with the AlphaVac system—APEX-AV—in the Journal of the Society for Cardiovascular Angiography &#38; Interventions (JSCAI). The primary efficacy endpoint of the APEX-AV trial was the reduction in right ventricle to left ventricle (RV/LV) ratio between baseline and 48 hours post-procedure.

## Lien source

https://cardiovascularnews.com/apex-av-trial-results-of-alphavac-pe-system-published-in-jscai/
